Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1351 to 1400 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dual specificity mitogen-activated protein kinase kinase 6 (ec 2.7.1.-) (map kinase kinase 6) (mapkk 6) (mapk/erk kinase 6) (sapkk3). [source:swissprot;acc:p52564]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6105.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6587.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07906\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dual specificity mitogen-activated protein kinase kinase 3 (ec 2.7.1.-) (map kinase kinase 3) (mapkk 3) (mapk/erk kinase 3). [source:swissprot;acc:p46734]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6104.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6586.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07902\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cyclin c. [source:swissprot;acc:p24863]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6200.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6690.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07896\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent actin, cytoplasmic 2 (gamma-actin). [source:swissprot;acc:p02571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6036.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6512.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07893\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ornithine carbamoyltransferase, mitochondrial precursor (ec 2.1.3.3) (otcase) (ornithine transcarbamylase). [source:swissprot;acc:p00480]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5783.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6240.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07889\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcipressin 1 (down syndrome critical region protein 1) (myocyte- enriched calcineurin interacting protein 1) (mcip1) (adapt78). [source:swissprot;acc:p53805]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5657.71\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 6103.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07881\vspace{3pt}}\\\cline{1-2}\cline{4-5} \parbox{\wcA}{\vspace{3pt}\noindent 1357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj947l8.1.6 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4w2]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6103.54\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.0788\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent zinc finger protein zic 4 (zinc finger protein of the cerebellum 4) (fragment). [source:swissprot;acc:q8n9l1]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj947l8.1.1 (novel cub and sushi (scr repeat) domain protein) (fragment). [source:sptrembl;acc:q9h4v7]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcipressin 2 (thyroid hormone-responsive protein zaki-4) (down syndrome candidate region 1-like 1) (myocyte-enriched calcineurin interacting protein 2) (mcip2). [source:swissprot;acc:q14206]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5657.72\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6103.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.07879\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcipressin 3 (down syndrome candidate region 1-like protein 2) (myocyte-enriched calcineurin interacting protein 3) (mcip3). [source:swissprot;acc:q9uka8]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sequestosome 1; ubiquitin-binding protein p62; phosphotyrosine independent ligand for the lck sh2 domain p62. [source:refseq;acc:nm\_003900]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6322.75\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6820.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.07872\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nonspecific lipid-transfer protein, mitochondrial precursor (nsl-tp) (sterol carrier protein 2) (scp-2) (sterol carrier protein x) (scp-x) (scpx). [source:swissprot;acc:p22307]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent protein c20orf4 (protein cgi-23) (pro0225). [source:swissprot;acc:q9y312]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5815.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6272.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07868\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma adducin (adducin-like protein 70). [source:swissprot;acc:q9uey8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5799.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6255.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07862\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent megf11 protein. [source:refseq;acc:nm\_032445]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5793.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6248.79\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.07858\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent megf10 protein. [source:refseq;acc:nm\_032446]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5793.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6248.71\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent beta adducin (erythrocyte adducin beta subunit). [source:swissprot;acc:p35612]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5793.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6248.51\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent alpha adducin (erythrocyte adducin alpha subunit). [source:swissprot;acc:p35611]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5786.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6241.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07853\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent t-complex associated-testis-expressed 1-like (protein 91/23). [source:swissprot;acc:p51808]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 10231.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 9487.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.07847\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent double-strand break repair protein mre11a (mre11 homolog 1). [source:swissprot;acc:p49959]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lin-7 homolog a; vertebrate lin7 homolog 1; tax interaction protein 33; mammalian lin-7 1. [source:refseq;acc:nm\_004664]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5743.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6193.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07835\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 3 (ec 2.7.1.37) (extracellular signal-regulated kinase 1) (erk-1) (insulin-stimulated map2 kinase) (map kinase 1) (mapk 1) (p44-erk1) (ert2) (p44-mapk) (microtubule- associated protein-2 kinase). [source:swissprot;acc:p27361]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6079.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6556.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07833\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s6 kinase alpha 3 (ec 2.7.1.37) (s6k-alpha 3) (90 kda ribosomal protein s6 kinase 3) (p90-rsk 3) (ribosomal s6 kinase 2) (rsk-2) (pp90rsk2) (insulin-stimulated protein kinase 1) (ispk-1). [source:swissprot;acc:p51812]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6079.45\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6555.4\vspace{3pt}}}&\multirow{14}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.07829\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium/calmodulin-dependent protein kinase type ii gamma chain (ec 2.7.1.123) (cam-kinase ii gamma chain) (cam kinase ii gamma subunit) (camk-ii gamma subunit) (fragment). [source:swissprot;acc:q13555]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium/calmodulin-dependent protein kinase type ii delta chain (ec 2.7.1.123) (cam-kinase ii delta chain) (cam kinase ii delta subunit) (camk-ii delta subunit). [source:swissprot;acc:q13557]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6079.46\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 6555.41\vspace{3pt}}&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase kinase kinase 6 (ec 2.7.1.-). [source:swissprot;acc:o95382]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6555.4\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 1378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent signal-induced proliferation-associated 1-like 1. [source:refseq;acc:nm\_015556]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6079.45\vspace{3pt}}&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s6 kinase alpha 1 (ec 2.7.1.37) (s6k-alpha 1) (90 kda ribosomal protein s6 kinase 1) (p90-rsk 1) (ribosomal s6 kinase 1) (rsk-1) (pp90rsk1). [source:swissprot;acc:q15418]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6079.46\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6555.41\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atp-binding cassette, sub-family d, member 3 (70 kda peroxisomal membrane protein) (pmp70). [source:swissprot;acc:p28288]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutaryl-coa dehydrogenase, mitochondrial precursor (ec 1.3.99.7) (gcd). [source:swissprot;acc:q92947]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histidine ammonia-lyase (ec 4.3.1.3) (histidase). [source:swissprot;acc:p42357]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s6 kinase alpha 6 (ec 2.7.1.37) (s6k-alpha 6) (90 kda ribosomal protein s6 kinase 6) (p90-rsk 6) (ribosomal s6 kinase 4) (rsk-4) (pp90rsk4). [source:swissprot;acc:q9uk32]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6079.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6555.4\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ribosomal protein s6 kinase alpha 2 (ec 2.7.1.37) (s6k-alpha 2) (90 kda ribosomal protein s6 kinase 2) (p90-rsk 2) (ribosomal s6 kinase 3) (rsk-3) (pp90rsk3). [source:swissprot;acc:q15349]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium/calmodulin-dependent protein kinase type ii alpha chain (ec 2.7.1.123) (cam-kinase ii alpha chain) (cam kinase ii alpha subunit) (camk-ii alpha subunit). [source:swissprot;acc:q9uqm7]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent calcium/calmodulin-dependent protein kinase type ii beta chain (ec 2.7.1.123) (cam-kinase ii beta chain) (cam kinase ii beta subunit) (camk-ii beta subunit). [source:swissprot;acc:q13554]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6079.46\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 6555.41\vspace{3pt}}&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase kinase kinase 5 (ec 2.7.1.-) (mapk/erk kinase kinase 5) (mek kinase 5) (mekk 5) (apoptosis signal- regulating kinase 1) (ask-1). [source:swissprot;acc:q99683]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 6555.4\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lin-7 homolog b; lin-7b protein; likely ortholog of mouse lin-7b; mammalian lin-7 protein 2; likely orholog of mouse lin 7 homolog b (c. elegans). [source:refseq;acc:nm\_022165]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5743.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6192.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07827\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 1 (ec 2.7.1.37) (extracellular signal-regulated kinase 2) (erk-2) (mitogen-activated protein kinase 2) (map kinase 2) (mapk 2) (p42-mapk) (ert1). [source:swissprot;acc:p28482]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6079.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6554.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07825\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent receptor protein-tyrosine kinase erbb-4 precursor (ec 2.7.1.112) (p180erbb4) (tyrosine kinase-type cell surface receptor her4). [source:swissprot;acc:q15303]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5743.36\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 6192.72\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.07824\vspace{3pt}}}\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent epidermal growth factor receptor precursor (ec 2.7.1.112) (receptor protein-tyrosine kinase erbb-1). [source:swissprot;acc:p00533]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6192.7\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent receptor protein-tyrosine kinase erbb-2 precursor (ec 2.7.1.112) (p185erbb2) (neu proto-oncogene) (c-erbb-2) (tyrosine kinase-type cell surface receptor her2) (mln 19). [source:swissprot;acc:p04626]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4} \parbox{\wcA}{\vspace{3pt}\noindent 1393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 2-hydroxyphytanoyl-coa lyase (ec 4.1.-.-) (2-hpcl) (hspc279). [source:swissprot;acc:q9uj83]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6192.72\vspace{3pt}}}&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent receptor protein-tyrosine kinase erbb-3 precursor (ec 2.7.1.112) (c-erbb3) (tyrosine kinase-type cell surface receptor her3). [source:swissprot;acc:p21860]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lin-7 homolog c; lin-7 protein 3. [source:refseq;acc:nm\_018362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5743.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6191.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07813\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent g-rich sequence factor-1 (grsf-1). [source:swissprot;acc:q12849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5803.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6256.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.07806\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 1397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein f (hnrnp f). [source:swissprot;acc:p52597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5803.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6256.23\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.07805\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein h (hnrnp h). [source:swissprot;acc:p31943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5803.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6256.05\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein h' (hnrnp h') (ftp-3). [source:swissprot;acc:p55795]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5803.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6256.03\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 1400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein h3 (hnrnp h3) (hnrnp 2h9). [source:swissprot;acc:p31942]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5803.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6256.43\vspace{3pt}}&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/